EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Management of patent foramen ovale-associated stroke: a review of closure vs. medical therapy

Yuanyuan Ma, Guo-Yuan Yang, Jing Ding, Xin Wang

Ageing and Neurodegenerative Diseases · 2025-05-23 · 5 (2)

DOI: 10.20517/and.2024.41 ↗
AbstractBibliografische Angaben

Abstract

Patent foramen ovale (PFO) is prevalent in approximately 25% of the general population and the incidence reaches up to 50% among patients with cryptogenic stroke (CS). Extensive research indicates that PFO is linked to paradoxical embolism, leading to CS, embolic stroke of undetermined source, and systemic embolization. Percutaneous PFO closure (PPFOC) has been a promising approach to prevent recurrent ischemic stroke, particularly in selected CS patients under 60 years with a high-risk PFO. Despite advancements, unresolved issues persist. In this review, we provide an updated overview of the diagnosis of high-risk PFOs and summarize recent insights into whether closure or medical therapy alone is effective for reducing recurrent ischemic stroke in CS patients with PFOs. Additionally, we present the current evidence about the safety and effectiveness of PFO percutaneous closure in elderly CS patients. Lastly, we discuss the incidence and the management of atrial fibrillation after PFO closure to guide clinicians in their decision making. Emphasizing the importance of comprehensive assessment, we advocate for a close multidisciplinary collaboration, including neurologists and cardiologists, to avoid unnecessary closure and associated complications in CS patients with a PFO.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →